P04629 (NTRK1_HUMAN) Homo sapiens (Human)
High affinity nerve growth factor receptor UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
64 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| TrkA ECD complex with designed miniprotein ligand |
Heteromer | 99.71 | 1×NAG; 6×NAG; 5×EDO; 5×SO4; | |||
| Structure of the extracellular segment of human TRKA in complex with nerve growth factor |
Heteromer P01138; | 100 | 2×NAG; 4×NAG; 6×NAG; | |||
| Crystal Structure of TrkA D5 domain in complex with two different macrocyclic peptides |
Heteromer | 100 | 4×EDO; | |||
| NGF IN COMPLEX WITH DOMAIN 5 OF THE TRKA RECEPTOR |
Heteromer P01138; | 100 | ||||
| SHC PTB DOMAIN COMPLEXED WITH A TRKA RECEPTOR PHOSPHOPEPTIDE, NMR, MINIMIZED AVERAGE STRUCTURE |
Heteromer P29353; | 100 | ||||
| TRK-A IN COMPLEX WITH LIGAND | homo-12-mer | 100.0 | 12×ZN; 12×OOY; 8×SRT; | |||
| Human TrkA in complex with the inhibitor AZ-23 | homo-12-mer | 100.0 | 12×V4Z; 24×ZN; | |||
| Crystal structure of TrkA kinase with ligand | homo-2-mer | 100.0 | 2×AQ6; | |||
| Human Nerve growth factor receptor TrkA | homo-2-mer | 100 | 2×GOL; | |||
| TrkA transmembrane domain NMR structure in DPC micelles | homo-2-mer | 97.37 | ||||
| TrkA JM-kinase with 1-(5-methyl-3-phenyl-1,2-oxazol-4-yl)-3-[[2-(trifluoromethyl)phenyl]methyl]urea | monomer | 100.0 | 1×6UH; | |||
| TrkA JM-kinase with 1-(2-methyl-4-phenyl-pyrimidin-5-yl)-3-[[2-(trifluoromethyl)phenyl]methyl]urea | monomer | 100.0 | 1×6UK; | |||
| Crystal structure of Tyrosine-protein kinase receptor in complex with 2,4-dichloro-N-(3-methyl-1-ph… | monomer | 100.0 | 1×FQJ; | |||
| Crystal structure of Tyrosine-protein kinase receptor in complex with 5-(4-fluorophenyl)thieno[2,3-… | monomer | 100.0 | 1×FQD; 1×FQG; | |||
| Crystal structure of Tyrosine-protein kinase receptor in complex with 5-(4-fluorophenyl)thieno[2,3-… | monomer | 100.0 | 1×FQD; 1×GOL; 1×FQM; | |||
| Crystal Structure of TrkA kinase with ligand | monomer | 100.0 | 1×7HF; 2×DTT; 1×NA; | |||
| TrkA JM-kinase with 1-(2-methyl-4-phenyl-pyrimidin-5-yl)-3-(1-naphthyl)urea | monomer | 100.0 | 1×6UJ; | |||
| TrkA JM-kinase with 2-fluoro-{N}-[2-(4-fluorophenyl)-6-methyl-3-pyridyl]-4-(trifluoromethyl)benzami… | monomer | 100.0 | 1×6UG; | |||
| TrkA JM-kinase with 1-(9{H}-fluoren-9-yl)-3-(2-methyl-4-phenyl-pyrimidin-5-yl)urea | monomer | 100.0 | 1×6UE; | |||
| TRK-A IN COMPLEX WITH LIGAND 6 | monomer | 100.0 | 1×L0M; | |||
| TRK-A IN COMPLEX WITH LIGAND 1 | monomer | 100.0 | 1×OO7; | |||
| The crystal structure of TrkA(F589L) kinase in complex with N-(3-cyclopropyl-5-((4-methylpiperazin-… | monomer | 99.66 | 1×A4U; | |||
| TrkA JM-kinase with {N}-(2-pyridylmethyl)-2-[2-(2-thienyl)indol-1-yl]acetamide | monomer | 100.0 | 1×6UF; | |||
| TRK-A IN COMPLEX WITH LIGAND 1 | monomer | 100.0 | 1×KWY; | |||
| Crystal structure of Trk-A complexed with a selective inhibitor CH7057288 | monomer | 100.0 | 1×RCH; | |||
| The crystal structure of human TrkA kinase bound to the inhibitor | monomer | 100 | 1×CVY; 1×CL; | |||
| The crystal structure of TrkA kinase in complex with 4^6,14-dimethyl-N-(3-(4-methyl-1H-imidazol-1-y… | monomer | 100.0 | 1×FKT; | |||
| Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 19. | monomer | 100.0 | 1×22L; 1×GOD; | |||
| Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 13b. | monomer | 100.0 | 1×22L; 1×GO7; | |||
| TRK-A IN COMPLEX WITH LIGAND 1a | monomer | 100 | 1×OOM; | |||
| TrkA JM-kinase with 1-(2-methyl-4-phenyl-pyrimidin-5-yl)-3-(2-pyridyl)urea | monomer | 100.0 | 1×6UM; | |||
| The crystal structure of TrkA kinase in complex with 4^6-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-… | monomer | 100.0 | 1×A6X; | |||
| The crystal structure of TrkA kinase in complex with 4^6-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-… | monomer | 100.0 | 1×A0X; | |||
| TRK-A IN COMPLEX WITH LIGAND 1B | monomer | 100.0 | 1×OOJ; | |||
| The crystal structure of TrkA(G595R) kinase in complex with N-(3-cyclopropyl-5-((4-methylpiperazin-… | monomer | 99.66 | 1×A4U; | |||
| TRK-A IN COMPLEX WITH LIGAND 1a | monomer | 100.0 | 1×OQJ; | |||
| TRK-A IN COMPLEX WITH LIGAND 9 | monomer | 100.0 | 1×L0P; | |||
| Crystal structure of the inactive TrkA kinase domain | monomer | 100.0 | ||||
| TRK-A IN COMPLEX WITH LIGAND | monomer | 100.0 | 1×OQS; | |||
| Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 10b. | monomer | 100.0 | 1×FKY; | |||
| TRK-A IN COMPLEX WITH LIGAND 1a | monomer | 100.0 | 1×OQM; | |||
| TRK-A IN COMPLEX WITH LIGAND 2a | monomer | 100.0 | 1×OOD; | |||
| Crystal structure of TrkA (G595R) kinase domain | monomer | 99.66 | ||||
| Crystal structure of Tyrosine-protein kinase receptor | monomer | 100 | ||||
| Crystal structure of TrkA (G595R) kinase with repotrectinib | monomer | 99.66 | 1×7GI; 5×SO4; | |||
| Crystal structure of TrkA in complex with PF-05247452 | monomer | 100.0 | 1×6K2; | |||
| Crystal structure of TrkA in complex with PF-05206283 | monomer | 100.0 | 1×6K1; | |||
| Crystal structure of TrkA in complex with PF-06273340 | monomer | 100.0 | 1×6K4; | |||
| (R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: a New Class of Potent and Selective Pan-TRK … | monomer | 100.0 | 1×4EK; 5×SO4; 1×GOL; | |||
| Crystal structure of TrkA in complex with PF-00593174 | monomer | 100.0 | 1×6K0; | |||
| Crystal structure of TrkA kinase with repotrectinib | monomer | 100 | 1×7GI; 5×SO4; | |||
| Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 3. | monomer | 100.0 | 1×GXA; | |||
| Crystal structure of apo TrkA | monomer | 100.0 | ||||
| (R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: a New Class of Potent and Selective Pan-TRK … | monomer | 100.0 | 1×4F6; 4×SO4; | |||
| Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 10e | monomer | 100.0 | 1×B9C; | |||
| The structure of TrkA kinase bound to the inhibitor 1-cyclopropyl-1-[3-(1,3-thiazol-2-yl)benzyl]-3-… | monomer | 100.0 | 1×31W; 1×CL; 3×ACT; | |||
| The structure of TrkA kinase bound to the inhibitor N-(3-cyclopropyl-1-phenyl-1H-pyrazol-5-yl)-2-{4… | monomer | 100.0 | 1×31V; 1×GOL; 1×CL; 3×ACT; | |||
| The structure of TrkA kinase bound to the inhibitor N~4~-(4-morpholin-4-ylphenyl)-N~6~-(pyridin-3-y… | monomer | 100.0 | 1×31Y; 1×CL; 3×ACT; | |||
| TrkA with (6~{R})-3-methylsulfanyl-6-phenyl-1-(1~{H}-pyrazol-3-yl)-6,7-dihydro-5~{H}-thieno[3,4-c]p… | monomer | 100.0 | 1×69C; 1×CL; 3×ACT; | |||
| THE STRUCTURE OF TRKA KINASE DOMAIN BOUND TO THE INHIBITOR ENTRECTINIB | monomer | 100.0 | 1×YMX; 1×GOL; | |||
| The structure of TrkA kinase bound to the inhibitor 4-naphthalen-1-yl-1-[(5-phenyl-1,2,4-oxadiazol-… | monomer | 100.0 | 1×31X; 1×CL; 3×ACT; | |||
| NGF BINDING DOMAIN OF HUMAN TRKA RECEPTOR | monomer | 100 | ||||
| Solution structure of a TrkAIg2 domain construct for use in drug discovery | monomer | 0.0 | ||||
| Crystal Structure of TrkA D5 domain in complex with macrocyclic peptide | monomer | 100 | 4×EDO; 1×GM1; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5kml.1.A | monomer | 0.78 | 100.00 | |||
| 2ifg.1.A | monomer | 0.69 | 100.00 | |||
7 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 5kml.1.A | monomer | 0.78 | 100.00 | |||
| Isoform 2 | 2ifg.1.A | monomer | 0.70 | 100.00 | |||
| Isoform 3 | 5kml.1.A | monomer | 0.78 | 100.00 | |||
| Isoform 3 | 2ifg.1.A | monomer | 0.69 | 99.05 | |||
| Isoform 4 | 5kml.1.A | monomer | 0.79 | 100.00 | |||
| Isoform 4 | 2ifg.1.A | monomer | 0.66 | 1×NAG; | 99.61 | ||
| Isoform 4 | 7n3t.1.A | monomer | 0.65 | 94.05 | |||